{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:48:14Z","timestamp":1787168894999,"version":"build-2736575974"},"reference-count":65,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDDT"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Obsessive-compulsive disorder (OCD) is a potentially debilitating disease\nthat affects 1-4% of the general population. It is characterized by the presence of obsessions and compulsions\nwhich interfere with the individual\u2019s life and functioning. Although conventional treatments\nsuch as drug therapies and cognitive behavioral therapy exist for OCD, these treatments are not universally\nsuccessful and can cause side effects, which has created a demand for alternative and complementary\ntherapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this review, we summarize randomized clinical trials on the effectiveness of herbal medicines\nfor the treatment of OCD, and review the possible mechanisms of action for these medicines. A\nsearch in PubMed, Scopus, and The Cochrane Library found 1022 studies, of which 7 were included\nin our review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The studies that we found were conducted over 6 to 12 weeks, and had an average sample\nsize of 37. The plant species studied included Crocus sativus, Echium amoenum, Hypericum perforatum,\nSilybum marianum, Valeriana officinalis, and Withania somnifera. The trials demonstrated the\neffectiveness of all plants as treatments for OCD except H. perforatum. The phytochemicals found in\nthese plants produce their effects through a variety of means such as inhibiting the reuptake of monoamines,\nGABAergic effects, and neuroendocrine modulation. The small number of studies and their\nsmall sample sizes, poor methodology, and lack of replication highlight the need for further research\ninto herbal medicines for the treatment of OCD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Overall, herbal medicines can be used as stand-alone therapies for OCD or in conjunction\nwith other methods.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1570163819666220616122543","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T05:37:39Z","timestamp":1655444259000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Evidence for the Effectiveness of Herbal Medicines in the Treatment\nof an Obsessive- Compulsive Disorder: A Review Study"],"prefix":"10.2174","volume":"19","author":[{"given":"Maryam Hosseini","family":"Abrishami","sequence":"first","affiliation":[{"name":"Department of Persian Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical\nSciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Reza","family":"Noras","sequence":"additional","affiliation":[{"name":"Department of Persian Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical\nSciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Soltanifar","sequence":"additional","affiliation":[{"name":"Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences,\nMashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshanak","family":"Salari","sequence":"additional","affiliation":[{"name":"Department of Clinical Persian Pharmacy, School of Persian and Complementary Medicine,\nMashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lida","family":"Jarahi","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Faculty of Medicine,\nMashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamideh Khorram","family":"Pazhouh","sequence":"additional","affiliation":[{"name":"Persian Medicine Research Center, School of Persian and\nComplementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/0974-8490.79118","volume":"3","author":"Prajapati R.P.","year":"2011","unstructured":"Prajapati R.P.; Kalaria M.V.; Karkare V.P.; Parmar S.K.; Sheth N.R.; Effect of methanolic extract of Lagenaria siceraria (Molina) standley fruits on marble-burying behavior in mice: Implications for obsessive-compulsive disorder. Pharmacognosy Res 2011,3(1),62-66","journal-title":"Pharmacognosy Res"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4103\/2231-0738.84188","volume":"1","author":"Prajapati R.","year":"2011","unstructured":"Prajapati R.; Kalariya M.; Umbarkar R.; Parmar S.; Sheth N.; Colocasia esculenta: A potent indigenous plant. Int J Nutr Pharmacol Neurol Dis 2011,1(2),90","journal-title":"Int J Nutr Pharmacol Neurol Dis"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4103\/2231-0738.84206","volume":"1","author":"Prajapati R.","year":"2011","unstructured":"Prajapati R.; Umbarkar R.; Parmar S.; Sheth N.; Antidepressant like activity of lagenaria siceraria (Molina) standley fruits by evaluation of the forced swim behavior in rats. Int J Nutr Pharmacol Neurol Dis 2011,1(2),152","journal-title":"Int J Nutr Pharmacol Neurol Dis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0193-953X(18)30207-7","volume":"15","author":"Swedo S.E.","year":"1992","unstructured":"Swedo S.E.; Leonard H.L.; Rapoport J.L.; Childhood-onset obsessive compulsive disorder. Psychiatr Clin North Am 1992,15(4),767-775","journal-title":"Psychiatr Clin North Am"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1542\/peds.23.2.371","volume":"23","author":"Glaser K.","year":"1959","unstructured":"Glaser K.; Problems in school attendance; school phobia and related conditions. Pediatrics 1959,23(2),371-383","journal-title":"Pediatrics"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1542\/peds.28.3.462","volume":"28","author":"Milman D.H.","year":"1961","unstructured":"Milman D.H.; School phobia in older children and adolescents: Diagnostic implications and prognosis. Pediatrics 1961,28(3),462-471","journal-title":"Pediatrics"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.21037\/tp.2019.10.02","volume":"9","author":"Nazeer A.","year":"2020","unstructured":"Nazeer A.; Latif F.; Mondal A.; Azeem M.W.; Greydanus D.E.; Obsessive-compulsive disorder in children and adolescents: Epidemiology, diagnosis and management. Transl Pediatr 2020,9(S1)(Suppl. 1),S76-S93","journal-title":"Transl Pediatr"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jpsychires.2014.06.010","volume":"57","author":"Shavitt R.G.","year":"2014","unstructured":"Shavitt R.G.; de Mathis M.A.; Oki F.; Phenomenology of OCD: Lessons from a large multicenter study and implications for ICD-11. J Psychiatr Res 2014,57,141-148","journal-title":"J Psychiatr Res"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"783-8","DOI":"10.1212\/01.CON.0000466666.12779.07","volume":"21","author":"Drubach DA","year":"2015","unstructured":"Drubach DA;  Obsessive-compulsive disorder 2015,21(3),783-8","journal-title":"Obsessive-compulsive disorder"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00127-010-0337-5","volume":"47","author":"Adam Y.","year":"2012","unstructured":"Adam Y.; Meinlschmidt G.; Gloster A.T.; Lieb R.; Obsessive-compulsive disorder in the community: 12-month prevalence, comorbidity and impairment. Soc Psychiatry Psychiatr Epidemiol 2012,47(3),339-349","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.4103\/psychiatry.IndianJPsychiatry_524_18","volume":"61","author":"Westwell-Roper C.","year":"2019","unstructured":"Westwell-Roper C.; Stewart S.E.; Challenges in the diagnosis and treatment of pediatric obsessive-compulsive disorder. Indian J Psychiatry 2019,61(7)(Suppl. 1),S119-S130","journal-title":"Indian J Psychiatry"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"348(apr07 6): g2183","DOI":"10.1136\/bmj.g2183","author":"Veale D","year":"2014","unstructured":"Veale D; Roberts A.; Obsessive-compulsive disorder. BMJ 2014,348(apr07 6): g2183","journal-title":"BMJ"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/01612840701354570","volume":"28","author":"Keeley M.L.","year":"2007","unstructured":"Keeley M.L.; Storch E.A.; Dhungana P.; Geffken G.R.; Pediatric obsessive-compulsive disorder: A guide to assessment and treatment. Issues Ment Health Nurs 2007,28(6),555-574","journal-title":"Issues Ment Health Nurs"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.psychres.2018.07.018","volume":"268","author":"Osland S.","year":"2018","unstructured":"Osland S.; Arnold P.D.; Pringsheim T.; The prevalence of diagnosed obsessive compulsive disorder and associated comorbidities: A population-based Canadian study. Psychiatry Res 2018,268,137-142","journal-title":"Psychiatry Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/mp.2008.94","volume":"15","author":"Ruscio A.M.","year":"2010","unstructured":"Ruscio A.M.; Stein D.J.; Chiu W.T.; Kessler R.C.; The epidemiology of obsessive-compulsive disorder in the national comorbidity survey replication. Mol Psychiatry 2010,15(1),53-63","journal-title":"Mol Psychiatry"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1017\/S1092852900007136","volume":"3","author":"Weissman M.M.","year":"1998","unstructured":"Weissman M.M.; Cross-national epidemiology of obsessive-compulsive disorder. CNS Spectr 1998,3(S1),6-9","journal-title":"CNS Spectr"},{"key":"ref=8","doi-asserted-by":"publisher","unstructured":"Diagnostic and statistical manual of mental disorders. Arlington: American Psychiatric Association 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0140-6736(09)60240-3","volume":"374","author":"Abramowitz J.S.","year":"2009","unstructured":"Abramowitz J.S.; Taylor S.; McKay D.; Obsessive-compulsive disorder. Lancet 2009,374(9688),491-499","journal-title":"Lancet"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1017\/S1352465817000844","volume":"46","author":"Collins L.M.","year":"2018","unstructured":"Collins L.M.; Coles M.E.; A preliminary investigation of pathways to inflated responsibility beliefs in children with obsessive compulsive disorder. Behav Cogn Psychother 2018,46(3),374-379","journal-title":"Behav Cogn Psychother"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13587-014-0013-6","volume":"4","author":"Rosso I.M.","year":"2014","unstructured":"Rosso I.M.; Olson E.A.; Britton J.C.; Brain white matter integrity and association with age at onset in pediatric obsessive-compulsive disorder. Biol Mood Anxiety Disord 2014,4(1),13","journal-title":"Biol Mood Anxiety Disord"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4088\/JCP.v67n0411","volume":"67","author":"Dell\u2019Osso B.","year":"2006","unstructured":"Dell\u2019Osso B.; Nestadt G.; Allen A.; Hollander E.; Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review. J Clin Psychiatry 2006,67(4),600-610","journal-title":"J Clin Psychiatry"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"747","DOI":"10.4088\/JCP.v68n0512","volume":"68","author":"Denys D.","year":"2007","unstructured":"Denys D.; Van Nieuwerburgh F.; Deforce D.; Westenberg H.G.; Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial. J Clin Psychiatry 2007,68(5),747-753","journal-title":"J Clin Psychiatry"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1017\/S1461145704004675","volume":"8","author":"Fineberg N.A.","year":"2005","unstructured":"Fineberg N.A.; Gale T.M.; Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol 2005,8(1),107-129","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1056\/NEJMcp031002","volume":"350","author":"Jenike M.A.","year":"2004","unstructured":"Jenike M.A.; Clinical practice. Obsessive-compulsive disorder. N Engl J Med 2004,350(3),259-265","journal-title":"N Engl J Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1002\/ptr.6656","volume":"34","author":"Ayati Z.","year":"2020","unstructured":"Ayati Z.; Sarris J.; Chang D.; Emami S.A.; Rahimi R.; Herbal medicines and phytochemicals for obsessive-compulsive disorder. Phytother Res 2020,34(8),1889-1901","journal-title":"Phytother Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1515\/revneuro-2015-0009","volume":"26","author":"Bahramsoltani R.","year":"2015","unstructured":"Bahramsoltani R.; Farzaei M.H.; Farahani M.S.; Rahimi R.; Phytochemical constituents as future antidepressants: A comprehensive review. Rev Neurosci 2015,26(6),699-719","journal-title":"Rev Neurosci"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1515\/revneuro-2014-0058","volume":"26","author":"Farahani M.S.","year":"2015","unstructured":"Farahani M.S.; Bahramsoltani R.; Farzaei M.H.; Abdollahi M.; Rahimi R.; Plant-derived natural medicines for the management of depression: An overview of mechanisms of action. Rev Neurosci 2015,26(3),305-321","journal-title":"Rev Neurosci"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.2174\/1568026616666160204121039","volume":"16","author":"Farzaei M.H.","year":"2016","unstructured":"Farzaei M.H.; Bahramsoltani R.; Rahimi R.; Abbasabadi F.; Abdollahi M.; A systematic review of plant-derived natural compounds for anxiety disorders. Curr Top Med Chem 2016,16(17),1924-1942","journal-title":"Curr Top Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.pnpbp.2011.02.011","volume":"35","author":"Camfield D.A.","year":"2011","unstructured":"Camfield D.A.; Sarris J.; Berk M.; Nutraceuticals in the treatment of obsessive compulsive disorder (OCD): A review of mechanistic and clinical evidence. Prog Neuropsychopharmacol Biol Psychiatry 2011,35(4),887-895","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","volume":"46","author":"Goodman W.K.","year":"1989","unstructured":"Goodman W.K.; Price L.H.; Rasmussen S.A.; The Yale-Brown obsessive compulsive scale: I. development, use, and reliability. Arch Gen Psychiatry 1989,46(11),1006-1011","journal-title":"Arch Gen Psychiatry"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.janxdis.2004.04.009","volume":"19","author":"Deacon B.J.","year":"2005","unstructured":"Deacon B.J.; Abramowitz J.S.; The Yale-Brown obsessive compulsive scale: Factor analysis, construct validity, and suggestions for refinement. J Anxiety Disord 2005,19(5),573-585","journal-title":"J Anxiety Disord"},{"key":"ref=17","first-page":"154","volume":"12","author":"Esalatmanesh S.","year":"2017","unstructured":"Esalatmanesh S.; Biuseh M.; Noorbala A.A.; Comparison of\nsaffron and fluvoxamine in the treatment of mild to moderate obsessive-\ncompulsive disorder: A double blind randomized clinical\ntrial. Iran J Psychiatry 2017,12(3),154-162","journal-title":"Iran J Psychiatry"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pnpbp.2005.10.005","volume":"30","author":"Sayyah M.","year":"2006","unstructured":"Sayyah M.; Sayyah M.; Kamalinejad M.; A preliminary randomized double blind clinical trial on the efficacy of aqueous extract of Echium amoenum in the treatment of mild to moderate major depression. Prog Neuropsychopharmacol Biol Psychiatry 2006,30(1),166-169","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.4088\/JCP.v61n0806","volume":"61","author":"Taylor L.H.","year":"2000","unstructured":"Taylor L.H.; Kobak K.A.; An open-label trial of St. John\u2019s Wort (Hypericum perforatum) in obsessive-compulsive disorder. J Clin Psychiatry 2000,61(8),575-578","journal-title":"J Clin Psychiatry"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/00004850-200511000-00003","volume":"20","author":"Kobak K.A.","year":"2005","unstructured":"Kobak K.A.; Taylor L.V.; Bystritsky A.; \nSt John\u2019s wort \nversus\nplacebo in obsessive-compulsive disorder: Results from a double-blind study.\n Int Clin Psychopharmacol 2005,20(6),299-304","journal-title":"Int Clin Psychopharmacol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.pnpbp.2009.12.016","volume":"34","author":"Sayyah M.","year":"2010","unstructured":"Sayyah M.; Boostani H.; Pakseresht S.; Malayeri A.; \nComparison of \nSilybum marianum\n(L.) Gaertn. with fluoxetine in the treatment of obsessive-compulsive disorder.\n Prog Neuropsychopharmacol Biol Psychiatry 2010,34(2),362-365","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=22","doi-asserted-by":"publisher","DOI":"10.2202\/1553-3840.1465","volume":"8","author":"Pakseresht S.","year":"2011","unstructured":"Pakseresht S.; Boostani H.; Sayyah M.; \nExtract of valerian root (\nValeriana officinalis\nL.)\nvs\n. placebo in treatment of obsessive-compulsive disorder: A randomized double-blind study.\n J Complement Integr Med 2011,8(1)","journal-title":"J Complement Integr Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ctim.2016.03.018","volume":"27","author":"Jahanbakhsh S.P.","year":"2016","unstructured":"Jahanbakhsh S.P.; Manteghi A.A.; Emami S.A.; Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: A randomized double-blind placebo-controlled trial. Complement Ther Med 2016,27,25-29","journal-title":"Complement Ther Med"},{"key":"ref=24","first-page":"64","volume":"50","author":"Kashani L.","year":"2017","unstructured":"Kashani L.; Eslatmanesh S.; Saedi N.; Comparison of saffron\nversus fluoxetine in treatment of mild to moderate postpartum depression:\nA double-blind, randomized clinical trial. Pharmacopsychiatry 2017,50(2),64-68","journal-title":"Pharmacopsychiatry"},{"key":"ref=25","first-page":"376","volume":"5","author":"Khazdair M.R.","year":"2015","unstructured":"Khazdair M.R.; Boskabady M.H.; Hosseini M.; Rezaee R.; M Tsatsakis A. The effects of Crocus sativus (saffron) and its constituents on nervous system: A review. Avicenna J Phytomed 2015,5(5),376-391","journal-title":"Avicenna J Phytomed"},{"key":"ref=26","first-page":"71","volume":"Vol. 9","author":"Hooper D.","year":"1937","unstructured":"Hooper D.; McNair J.B.; Field H.;  Field Museum of Natural History 1937,Vol. 9,71-241","journal-title":"Field Museum of Natural History"},{"key":"ref=27","first-page":"21","volume":"4","author":"Abed A.","year":"2014","unstructured":"Abed A.; Vaseghi G.; Jafari E.; Fattahian E.; Babhadiashar N.; Abed M.; Echium Amoenum Fisch. Et Mey: A review on its pharmacological\nand medicinal properties. Asian J Med Pharm Res 2014,4,21-23","journal-title":"Asian J Med Pharm Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.euroneuro.2011.04.002","volume":"21","author":"Sarris J.","year":"2011","unstructured":"Sarris J.; Panossian A.; Schweitzer I.; Stough C.; Scholey A.; Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol 2011,21(12),841-860","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1089\/acm.2009.0066","volume":"15","author":"Sarris J.","year":"2009","unstructured":"Sarris J.; Kavanagh D.J.; Kava and St. John\u2019s Wort: Current evidence for use in mood and anxiety disorders. J Altern Complement Med 2009,15(8),827-836","journal-title":"J Altern Complement Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"e100159","DOI":"10.1136\/gpsych-2019-100159","volume":"33","author":"Karc\u0131 K.C.","year":"2020","unstructured":"Karc\u0131 K.C.; Celik G.G.; Nutritional and herbal supplements in the treatment of obsessive compulsive disorder. Gen Psychiatr 2020,33(2),e100159","journal-title":"Gen Psychiatr"},{"key":"ref=31","first-page":"3","volume":"66","author":"Morazzoni P.","year":"1995","unstructured":"Morazzoni P.; Bombardelli E.; Silybum marianum (Carduus marianus). Fitoterapia 1995,66(1),3-42","journal-title":"Fitoterapia"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1006\/bbrc.1997.7375","volume":"239","author":"Zi X.","year":"1997","unstructured":"Zi X.; Mukhtar H.; Agarwal R.; Novel cancer chemopreventive effects of a flavonoid antioxidant silymarin: Inhibition of mRNA expression of an endogenous tumor promoter TNF &#x3B1;. Biochem Biophys Res Commun 1997,239(1),334-339","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.2042-7158.1996.tb06014.x","volume":"48","author":"De La Puerta R.","year":"1996","unstructured":"De La Puerta R.; Martinez E.; Bravo L.; Ahumada M.C.; Effect of silymarin on different acute inflammation models and on leukocyte migration. J Pharm Pharmacol 1996,48(9),968-970","journal-title":"J Pharm Pharmacol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jep.2004.01.008","volume":"91","author":"Maghrani M.","year":"2004","unstructured":"Maghrani M.; Zeggwagh N-A.; Lemhadri A.; El Amraoui M.; Michel J-B.; Eddouks M.; Study of the hypoglycaemic activity of Fraxinus excelsior and Silybum marianum in an animal model of type 1 diabetes mellitus. J Ethnopharmacol 2004,91(2-3),309-316","journal-title":"J Ethnopharmacol"},{"key":"ref=35","first-page":"56","volume":"2","author":"Mikaili P.","year":"2011","unstructured":"Mikaili P.; Shayegh J.; Asghari M.H.; Sarahroodi S.; Sharifi M.; Currently\nused traditional phytomedicines with hot nature in Iran. Biol Res 2011,2(5),56-68","journal-title":"Biol Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1055\/s-2006-962221","volume":"55","author":"H&#xF6;lzl J.","year":"1989","unstructured":"H&#xF6;lzl J.; Godau P.; Receptor bindings studies with Valeriana officinalis on the benzodiazepine receptor. Planta Med 1989,55(07),642-2","journal-title":"Planta Med"},{"key":"ref=b","first-page":"291","volume":"64","author":"Mennini T.","year":"1993","unstructured":"Mennini T.; Bernasconi P.; Bombardelli E.; Morazzoni P.; In vitro\nstudy on the interaction of extracts and pure compounds from\nValeriana officinalis roots with GABA. benzodiazepine and barbiturate\nreceptors in rat brain. Fitoterapia 1993,64,291-1","journal-title":"Fitoterapia"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuropharm.2007.04.018","volume":"53","author":"Khom S.","year":"2007","unstructured":"Khom S.; Baburin I.; Timin E.; Valerenic acid potentiates and inhibits GABA(A) receptors: Molecular mechanism and subunit specificity. Neuropharmacology 2007,53(1),178-187","journal-title":"Neuropharmacology"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ptr.1027","volume":"16","author":"Andreatini R.","year":"2002","unstructured":"Andreatini R.; Sartori V.A.; Seabra M.L.; Leite J.R.; Effect of valepotriates (valerian extract) in generalized anxiety disorder: A randomized placebo-controlled pilot study. Phytother Res 2002,16(7),650-654","journal-title":"Phytother Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.bcp.2006.09.029","volume":"73","author":"Lacher S.K.","year":"2007","unstructured":"Lacher S.K.; Mayer R.; Sichardt K.; Nieber K.; M&#xFC;ller C.E.; Interaction of valerian extracts of different polarity with adenosine receptors: Identification of isovaltrate as an inverse agonist at A1 receptors. Biochem Pharmacol 2007,73(2),248-258","journal-title":"Biochem Pharmacol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s11064-009-9987-7","volume":"34","author":"Bhatnagar M.","year":"2009","unstructured":"Bhatnagar M.; Sharma D.; Salvi M.; Neuroprotective effects of Withania somnifera dunal.: A possible mechanism. Neurochem Res 2009,34(11),1975-1983","journal-title":"Neurochem Res"},{"key":"ref=40","first-page":"129","volume":"1","author":"Gupta G.L.","year":"2007","unstructured":"Gupta G.L.; Rana A.; Withania somnifera (Ashwagandha): A\nreview. Pharmacogn Rev 2007,1(1),129-136","journal-title":"Pharmacogn Rev"},{"key":"ref=b","first-page":"334","volume":"5","author":"Mishra L-C.","year":"2000","unstructured":"Mishra L-C.; Singh B.B.; Dagenais S.; Scientific basis for the\ntherapeutic use of Withania somnifera (ashwagandha): A review. Altern Med Rev 2000,5(4),334-346","journal-title":"Altern Med Rev"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1515\/DMDI.2003.19.3.211","volume":"19","author":"Gupta S.K.","year":"2003","unstructured":"Gupta S.K.; Dua A.; Vohra B.P.; Withania somnifera (Ashwagandha) attenuates antioxidant defense in aged spinal cord and inhibits copper induced lipid peroxidation and protein oxidative modifications. Drug Metabol Drug Interact 2003,19(3),211-222","journal-title":"Drug Metabol Drug Interact"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0944-7113(00)80030-6","volume":"7","author":"Bhattacharya S.K.","year":"2000","unstructured":"Bhattacharya S.K.; Bhattacharya A.; Sairam K.; Ghosal S.; Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: An experimental study. Phytomedicine 2000,7(6),463-469","journal-title":"Phytomedicine"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29252\/jmp.3.71.1","volume":"3","author":"Zamani Z.","year":"2019","unstructured":"Zamani Z.; Akhondzadeh S.; Herbal medicine in the treatment of obsessive compulsive disorder: A Review. Faslnamah-i Giyahan-i Daruyi 2019,3(71),1-5","journal-title":"Faslnamah-i Giyahan-i Daruyi"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4088\/JCP.v64n0508","volume":"64","author":"Hollander E.","year":"2003","unstructured":"Hollander E.; Friedberg J.; Wasserman S.; Allen A.; Birnbaum M.; Koran L.M.; Venlafaxine in treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 2003,64(5),546-550","journal-title":"J Clin Psychiatry"},{"key":"ref=44","first-page":"885","author":"Jenike M.A.","year":"1998","unstructured":"Jenike M.A.; Baer L.; Minichiello W.E.;  Obsessive-compulsive disorders: Practical management 1998,885","journal-title":"Obsessive-compulsive disorders: Practical management"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/1534735407301942","volume":"6","author":"Tamayo C.","year":"2007","unstructured":"Tamayo C.; Diamond S.; \nReview of clinical trials evaluating safety and efficacy of milk thistle (\nSilybum marianum\n[L. Gaertn.).\n Integr Cancer Ther 2007,6(2),146-157","journal-title":"Integr Cancer Ther"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.phymed.2008.06.003","volume":"15","author":"Modaghegh M-H.","year":"2008","unstructured":"Modaghegh M-H.; Shahabian M.; Esmaeili H-A.; Rajbai O.; Hosseinzadeh H.; Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine 2008,15(12),1032-1037","journal-title":"Phytomedicine"}],"container-title":["Current Drug Discovery Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570163819666220616122543","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/206086\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570163819666220616122543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T12:26:49Z","timestamp":1665059209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/206086\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570163819666220616122543","relation":{},"ISSN":["1570-1638"],"issn-type":[{"value":"1570-1638","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-10-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e160622206086"}}